openPR Logo
Press release

Pharmaceutical Excipients Market Exploration on Eminent Players - Evonik Industries, FMC Corporation, Croda International PLC, Ashland Inc., Roquette Group, Lubrizol Corporation, Innophos Holdings Inc. and MEGGLE Group Wasserburg BG Excipients & Technolog

10-20-2018 09:09 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Pharmaceutical Excipients

Pharmaceutical Excipients

Pharmaceutical excipients are crucial contents of a formulation that enable effective drug absorption. Excipients must suit the intended dosage form and comply with regulatory requirements i.e. pharmacopeial standards to ensure finished product quality. Moreover, their compatibility is crucial in dosage forms that involves taste masking, coating, controlled and sustained release, and oil base (emulsifiers). The International Pharmaceutical Excipient Councils (IPE) governs the global pharmaceutical excipient manufacturing by providing harmonized excipient guidelines to manufacturers.

Download PDF Brochure : https://www.coherentmarketinsights.com/insight/request-pdf/124

Excipients used in drug manufacturing serve as binders, diluents, glidents, or disintegrants. Thus, multifunctional excipients can lower the drug development and manufacturing cost of the product. Generics market has witnessed robust growth in recent times, owing to patent expiries, in turn acting as a major factor driving demand for pharmaceutical excipients. Moreover, meeting growing demand for pharmaceutical products and large patient population base would propel growth of pharmaceutical excipients market.

Excipients are largely used in the production of oral dosage forms such as tablets, capsules, and liquids when compared to parenteral dosage forms. The growth of excipients usage in oral dosage forms is expected to be 7.2% over the forecast period. Local players entering the pharmaceutical industry mark their entry with oral dosage forms, as manufacturing of these are easier when compared to other dosage forms.

Pharmaceutical Excipients Market Players:

BASF SE, The DOW Chemical Company, Evonik Industries, FMC Corporation, Croda International PLC, Ashland Inc., Roquette Group, Lubrizol Corporation, Innophos Holdings Inc. and MEGGLE Group Wasserburg BG Excipients & Technology

Request For Customization of Research Report : https://www.coherentmarketinsights.com/insight/request-customization/124

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Excipients Market Exploration on Eminent Players - Evonik Industries, FMC Corporation, Croda International PLC, Ashland Inc., Roquette Group, Lubrizol Corporation, Innophos Holdings Inc. and MEGGLE Group Wasserburg BG Excipients & Technolog here

News-ID: 1316146 • Views:

More Releases from Coherent Market Insights

Malt Ingredient Market Set to Boom: Strategic Insights and Growth Opportunities with Key Players Like Axereal Group, Cargill, Incorporated, RAGLETH LTD
Malt Ingredient Market Set to Boom: Strategic Insights and Growth Opportunities …
The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Malt Ingredient Market. From 2025 to 2032, this study delivers key insights, clear segmentation and actionable intelligence to help decision-makers navigate the evolving Malt Ingredient Market and capitalise on upcoming opportunities. Report Highlights • Strategic coverage of investment hotspots, regional trend shifts and emerging segments. • Deep
Mannosylerythritol Lipids Market Poised for Strong Growth: New Report Highlights Growth Potential Through 2032
Mannosylerythritol Lipids Market Poised for Strong Growth: New Report Highlights …
The latest report by Coherent Market Insights indicates strong growth potential for the Mannosylerythritol Lipids Market from 2025 to 2032, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers a clear overview of market size, revenue trends, and key growth factors shaping the global landscape. This research analyzes major market drivers, restraints, challenges, and emerging opportunities, while highlighting innovation trends and financial insights influencing competitive
Asia Pacific Halal Cosmetic Market Forecast Through 2032 Highlights Emerging Trends and Strategic Growth Factors | INKIA, Martha Tilaar Group, Wipro Unza, Clara International
Asia Pacific Halal Cosmetic Market Forecast Through 2032 Highlights Emerging Tre …
The Global Business Landscape is being reshaped by rapid innovation, rising investment and shifting regional dynamics - and at the heart of this transformation lies the Asia Pacific Halal Cosmetic Market. From 2025 to 2032, this study delivers key insights, clear segmentation and actionable intelligence to help decision-makers navigate the evolving Asia Pacific Halal Cosmetic Market and capitalise on upcoming opportunities. Report Highlights • Strategic coverage of investment hotspots, regional trend shifts
Radiodermatitis Market Growth in Future Scope 2025-2032 | Acelity, Inc. (3M) BMG Pharma S.r.l., ConvaTec Group PLC, DermaSciences Inc. (Integra LifeSciences Holdings Corporation)
Radiodermatitis Market Growth in Future Scope 2025-2032 | Acelity, Inc. (3M) BMG …
Radiodermatitis Market is estimated to be valued at USD 442.8 Mn in 2025 and is expected to reach USD 594.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032. The latest report by Coherent Market Insights indicates strong growth potential for the Radiodermatitis Market from 2025 to 2032, supported by rising industry demand, expanding applications, and ongoing technological advancements. The study delivers a clear

All 5 Releases


More Releases for Excipient

Chronic Disease Rise Fuels Albumin Excipient Market Growth: The Driving Engine B …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Albumin Excipient Market Size Growth Forecast: What to Expect by 2025? The size of the albumin excipient market has been witnessing significant growth in recent years. It is estimated to rise from $4.85 billion in 2024 to $5.15 billion in 2025 with a Compound Annual Growth Rate (CAGR) of
Biological Excipient Market Key Drivers for 2025
The Biological Excipient market is a crucial segment of the pharmaceutical industry, providing essential support for the efficacy and stability of drug formulations. Biological excipients are naturally derived substances that facilitate the delivery of active pharmaceutical ingredients (APIs), ensuring that medications retain their intended therapeutic effects while enhancing patient compliance and safety. The relevance of this market spans a wide range of applications, including oral and topical formulations, which cater
Biopharmaceutical Excipient Market Growth Fueled by Rising Biologics Demand.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biopharmaceutical Excipient Manufacturing Market- by Type of Biologics (Antibodies, Vaccines, Cell Therapies and Other Biologics), Type of Excipient (Carbohydrates, Polymers, Solubilizers/Surfactants, Polyols, Proteins/Amino Acids and Others), Scale of Operation (Preclinical, Clinical and Commercial), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by InsightAce Analytic, the global Biopharmaceutical Excipient Manufacturing market
Biopharmaceutical Excipient Manufacturing: Driving Efficiency in Pharmaceutical …
"Biopharmaceutical Excipient Manufacturing Market" in terms of revenue was estimated to be worth $1,372.7 Mn in 2023 and is poised to reach $2,892.5 Mn by 2031, growing at a CAGR of 9.82% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1197 Market Analysis: Biopharmaceutical excipients serve an important role in biologic drug formulation by stabilizing, delivering, and improving the performance of active pharmaceutical
Isotope-Labeled Excipient Market Revenue, Insights, Overview, Outlook, Analysis
Isotope-Labeled Excipient Market Isotopic labeling is a technique which identifies drug products and detects counterfeits. Over the globe, pharmaceutical companies face a major problem of drug counterfeit, and the adoption of isotope-labeled excipients helps in reducing such products which are either manufactured with no active pharmaceutical ingredients (API), wrong API, or an incorrect amount of API. Counterfeiting issues are a major concern in the pharmaceutical market owing to poor regulatory scenario,
Global Pharmaceutical Excipient Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pharmaceutical Excipient Market is projected to grow from USD 8.6 Billion in 2022 to USD 11.5 billion in 2027 at a CAGR of 5.9% from 2022 to 2027. The increase in demand for oral solid pharmaceutical drugs, the emergence of novel therapeutics on account of the growing number of pharmaceutical companies, the rapidly growing pharmaceuticals market, and